Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan

Atherosclerosis

Volumn 214, Issue 2, 2011, Pages 404-407

  Mabuchi, Hiroshi ^a   Nohara, Atsushi ^a   Noguchi, Tohru ^a   Kobayashi, Junji ^a   Kawashiri, Masa aki ^a   Tada, Hayato ^a   Nakanishi, Chiaki ^a   Mori, Mika ^a   Yamagishi, Masakazu ^a   Inazu, Akihiro ^a   Koizumi, Junji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

DNA analysis of FH genes; Familial hypercholesterolemia (FH); Genetic epidemiology of homozygous FH; Incidence of FH

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DNA DETERMINATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC EPIDEMIOLOGY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INCIDENCE; INFANT; JAPAN; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; AGED; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INCIDENCE; INFANT; JAPAN; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, LDL; RISK ASSESSMENT; RISK FACTORS; SERINE ENDOPEPTIDASES; YOUNG ADULT;

EID: 79151482125     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.005     Document Type: Article

References (13)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. The metabolic and molecular bases of inherited disease 2000, 2895. McGraw-Hill Professional. 8th ed. C. Scriver, A. Beaudet, W. Sly, D. Valle, B. Childs, K. Kinzler, B. Vogelstein (Eds.).
2. Soutar A.K., Naoumova R.P. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 2007, 4(4):214-225.
3. Mabuchi H., Higashikata T., Nohara A., et al. Cutoff point separating affected and unaffected familial hypercholesterolemic patients validated by LDL-receptor gene mutants. J Atheroscler Thromb 2005, 12(1):35-40.
4. Scientific Steering Committee on behalf of the Simon Broome Register Group Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991, 303(6807):893-896.
5. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
6. Noguchi T., Katsuda S., Kawashiri M.A., et al. The E32K variant of PCSK9 exacerbates the phenotype of familial hypercholesterolemia by increasing PCSK9 function and concentration in the circulation. Atherosclerosis 2010, 210(1):166-172.
7. Yu W., Nohara A., Higashikata T., et al. Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population. Atherosclerosis 2002, 165(2):335-342.
8. Nohara A., Yagi K., Inazu A., et al. Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia. Lancet 1995, 345(8962):1438.
9. Mabuchi H., Tatami R., Haba T., et al. Homozygous familial hypercholesterolemia in Japan. Am J Med 1978, 65(2):290-297.
10. Kolansky D.M., Cuchel M., Clark B.J., et al. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia. Am J Cardiol 2008, 102(11):1438-1443.
11. Goldstein J.L., Schrott H.G., Hazzard W.R., et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973, 52(7):1544-1568.
12. Slack J. Inheritance of familial hypercholesterolemia. Atheroscler Rev 1979, 5:35-66.
13. Khachadurian A.K. The inheritance of essential familial hypercholesterolemia. Am J Med 1964, 37:402-407.